🎁 Black Friday: up to 50% off of annual plans
Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
2.350
+0.030 (1.29%)
Nov 20, 2026, 4:00 PM EST - Market closed

Neuphoria Therapeutics Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Revenue
1.171.1715.65--0.18
Other Revenue
-----3.99
1.171.1715.65--4.17
Revenue Growth
-92.50%-92.50%---499.60%
Cost of Revenue
-----11.02
Gross Profit
1.171.1715.65---6.85
Selling, General & Admin
7.677.447.778.478.915.28
Research & Development
-0.912.748.719.3212.65-
Other Operating Expenses
------0
Operating Expenses
6.7610.1816.4817.821.565.27
Operating Income
-5.58-9.01-0.83-17.8-21.56-12.12
Interest Expense
------0.02
Interest & Investment Income
0.690.670.170.220.320.01
Currency Exchange Gain (Loss)
-0.67-0.54-0.41-0.210.310.25
Other Non Operating Income (Expenses)
5.16----0.59-2.59
EBT Excluding Unusual Items
-0.4-8.88-1.08-17.79-21.52-14.48
Merger & Restructuring Charges
-1.28-1.28----
Impairment of Goodwill
-5.36-5.36----
Gain (Loss) on Sale of Investments
1.931.930.242.21--
Gain (Loss) on Sale of Assets
------0
Other Unusual Items
------0.65
Pretax Income
-5.11-13.59-0.84-15.58-21.52-15.12
Income Tax Expense
-0.14-0.14-0.47-0.09-0.14-0.13
Earnings From Continuing Operations
-4.97-13.45-0.37-15.49-21.38-14.99
Net Income
-4.97-13.45-0.37-15.49-21.38-14.99
Net Income to Common
-4.97-13.45-0.37-15.49-21.38-14.99
Net Income Growth
------
Shares Outstanding (Basic)
54211,4691,353
Shares Outstanding (Diluted)
54211,4691,353
Shares Change
178.96%170.85%95.01%-99.94%8.53%73.52%
EPS (Basic)
-0.96-3.06-0.23-18.62-0.01-0.01
EPS (Diluted)
-0.96-3.06-0.23-18.62-0.01-0.01
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-9.69-12.350.08-14.68-14.64-14.99
Free Cash Flow Per Share
-1.87-2.810.05-17.64-0.01-0.01
Gross Margin
100.00%100.00%100.00%---164.21%
Operating Margin
-475.60%-767.32%-5.30%---290.62%
Profit Margin
-423.32%-1145.66%-2.36%---359.34%
Free Cash Flow Margin
-825.01%-1052.07%0.49%---359.30%
EBITDA
-4.92-8.35-0.17-17.13-20.9-11.49
EBITDA Margin
---1.06%---275.36%
D&A For EBITDA
0.660.660.660.660.660.64
EBIT
-5.58-9.01-0.83-17.8-21.56-12.12
EBIT Margin
---5.30%---290.62%
Revenue as Reported
1.171.1715.65---
SEC Filings: 10-K · 10-Q